Patients with rheumatoid arthritis who use biological DMARDs are unlikely to achieve sustained DMARD-free remission.

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in RA.

Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.

Therapy for inflammatory joint diseases, such as rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, includes various conventional disease-modifying antirheumatic drugs (DMARDs).

Discover how rheumatoid arthritis advances through distinct stages, the symptoms at each phase, and treatment approaches that ...

Rheumatoid arthritis (RA) treatment usually includes antirheumatic drugs (DMARDs) combined with nonsteroidal anti-inflammatory drugs and low-dose steroids. Steroids are technically called ...

Rheumatoid arthritis neuropathy occurs when inflammation or other factors related to RA affect the peripheral nervous system.

Aggressive early use of DMARDs is indicated for patients with RA to prevent joint damage and improve physical function as well as health-related quality of life. Targeting patient outcomes with ...

The BRAVE-AA-PEDS trial found that once-daily baricitinib significantly improved hair regrowth on the scalp, eyebrows, and ...

Iguratimod (IGU) is a disease-modifying anti-rheumatic drug (DMARD) that treats rheumatoid arthritis (RA) and other ...

Rheumatoid arthritis can be hard to live with, so managing stress is key. Exercising, journaling, connecting with others, and ...

Rheumatoid arthritis (RA) is a chronic ... while disease-modifying antirheumatic drugs (DMARDs) are required to inhibit or halt the underlying immune process and prevent long-term damage.